Results 81 to 90 of about 3,861 (173)

Meta analysis of efficiency and safety of sevelamer in the treatment of hyperphosphatemia in patients with maintenance hemodialysis

open access: yesLinchuang shenzangbing zazhi, 2018
Objective The objective of this review is to inquire the efficiency and safety of sevelamer to decrease the level of serum phosphate of the patients with maintenance hemodialysis.Methods According to the strict inclusion and exclusion criteria we search ...
YANG Ling
doaj  

Supplementary Material for: Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis

open access: yes
Introduction Case reports have suggested a causative role between sevelamer use and subsequent gastrointestinal bleeding (GIB), but no large observational studies have evaluated this association.
Coresh J. (4122835)   +4 more
core   +1 more source

Sulfonic acid-functionalized polyallylamine (sevelamer) as an efficient reusable strong solid acid catalyst for the synthesis of xanthenes derivatives

open access: yesBMC Chemistry, 2019
Sevelamer (polyallyamine resin)-supported sulfonic acid (S-SO3H) has been prepared from the reaction of sevelamer with chlorosulfonic acid and characterized using FT-IR spectroscopy, scanning electronmicroscopy (SEM) and thermogravimetric analysis (TGA).
Xian-Liang Zhao   +2 more
doaj   +1 more source

Whitish Deposits in the Stomach and Duodenum

open access: yes
United European Gastroenterology Journal, Volume 13, Issue 10, Page 1913-1915, December 2025.
Kai‐yan Yang, Xu‐jie Zhou, Wei Xie
wiley   +1 more source

Forest plot of sevelamer vs. calcium phosphate binders on CACS change.

open access: yes, 2015
Forest plot of sevelamer vs. calcium phosphate binders on CACS change.
Yongming Zhou (429711)   +6 more
core   +1 more source

Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients.

open access: yes, 2010
Sevelamer hydrochloride (HCl), a calcium-free phosphate binder, is increasingly used due to concerns related to calcium exposure and the development of vascular calcifications.
Amin, Nimisha   +4 more
core   +1 more source

PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.

open access: yesPLoS ONE, 2017
The effects of PA21, a novel iron-based and non-calcium-based phosphate binder, on hyperphosphatemia and its accompanying bone abnormality in chronic kidney disease-mineral and bone disorder (CKD-MBD) were evaluated.
Atsushi Yaguchi   +3 more
doaj   +1 more source

Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo

open access: yesNefrología, 2015
El sevelamer es un captor no cálcico de fósforo que se utiliza en la ERC avanzada y en diálisis para el control de la hiperfosforemia. Varios estudios experimentales, observacionales y ensayos clínicos han mostrado que el sevelamer tiene efectos ...
Laura Rodríguez-Osorio   +6 more
doaj   +1 more source

Effect of sevelamer on aortic pulse wave velocity in patients on hemodialysis: a prospective observational study

open access: yes, 2017
Aortic stiffening and aortic calcification are risk factors for cardiovascular events in hemodialysis (HD) patients, and these 2 risk factors are interrelated.
Fodor E   +11 more
core   +1 more source

A Case of Crystal-Associated Colitis Caused by Sevelamer

open access: yesAnnals of Internal Medicine: Clinical Cases
Sevelamer, a calcium-free phosphate binder used in chronic kidney disease, can lead to gastrointestinal side effects and, rarely, crystal-associated colitis. We present a case of sevelamer-induced colitis in a 66-year-old man with end-stage renal disease.
Ryan Plunkett   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy